Production of monoclonal antibodies (mAbs) against oralcarcinoma & its bioconjugation with solid lipid nanoparticles (SLN) for drug delivery
Sanskruti Shrenik Patil, Kusuma Kumari Garikapati, Tallapaneni Vyshnavi, Abhishek Dey, Vasanth Raj Palanimuthu · 2026
Read Production of monoclonal antibodies (mAbs) against oralcarcinoma & its bioconjugation with solid lipid nanoparticles (SLN) for drug delivery by Sanskruti Shrenik Patil, Kusuma Kumari Garikapati, Tallapaneni Vyshnavi, Abhishek Dey, Vasanth Raj Palanimuthu (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13391474.txt.
Description
Sanskruti Shrenik Patil's team joint carboplatin-loaded solid lipid nano bits with tumour-aimed immune drugs for oral cancer therapy in an early study. Mice primed with KB oral cancer cells made antigen-specific immune drugs, and spleen cells fused with marrow-cancer cells yielded hybrids, with the third fusion attempt optimal.
Lipid nano bits near 145 nm with good charge killed oral flat-cell cancer cells in time- and dose-linked fashion, outperforming free carboplatin. The dual immune-drug-plus-nano-bit strategy shows promise for targeted oral cancer drug delivery, though the work remains early-stage and pre-human.
Catalog record
| CREATOR | Sanskruti Shrenik Patil, Kusuma Kumari Garikapati, Tallapaneni Vyshnavi, Abhishek Dey, Vasanth Raj Palanimuthu |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 37 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |